Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
MedTech
Thermo Fisher debuts protein panel for neurodegeneration R&D
The addition of the multiplex immunoassay panel to the company’s Target 48 proteomics line follows last year’s $3.1 billion acquisition of Olink.
Conor Hale
Sep 16, 2025 12:00pm
Galimedix's oral Alzheimer's candidate clears ph. 1 safety test
Sep 12, 2025 11:11am
AC Immune cuts workforce by 30%, trims pipeline to preserve cash
Sep 4, 2025 10:27am
Prothena Alzheimer's trial hit by ARIA showstopper
Aug 28, 2025 6:48am
Lighthouse nabs $49M grant for bacteria-related Alzheimer's test
Aug 22, 2025 8:07am
Denali Alzheimer's antibody clears plaques without ARIA in mice
Aug 7, 2025 2:00pm
